Evidence map›Paper›PMID 32886716›Full record

ArticlePLoS pathogens2020

Human cytomegalovirus evades ZAP detection by suppressing CpG dinucleotides in the major immediate early 1 gene.

Yao-Tang Lin, Stephen Chiweshe, Dominique McCormick, Anna Raper, Arthur Wickenhagen, Victor DeFillipis, Eleanor Gaunt, Peter Simmonds, Sam J Wilson, Finn Grey

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy.Journal of experimental & clinical cancer research : CR · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Yao-Tang LinDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.ORCID 0000-0002-8017-1015
Stephen ChiwesheDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
Dominique McCormickDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.ORCID 0000-0001-7539-5033
Anna RaperDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.ORCID 0000-0003-0949-9963
Arthur WickenhagenMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0001-5470-1505
Victor DeFillipisVaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, Oregon, United States of America.ORCID 0000-0003-1699-9798
Eleanor GauntDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.ORCID 0000-0002-4473-6373
Peter SimmondsPeter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Sam J WilsonMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.ORCID 0000-0002-6065-0895
Finn GreyDivision of Infection and Immunity, The Roslin Institute, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.ORCID 0000-0003-4288-2059
Roslin Institute · GBMRC University of Glasgow Centre for Virus Research · GBOregon Health & Science University · USUniversity of Oxford · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/D/20002172Medical Research Council MC_UU_12014/10Medical Research Council MR/K024752/1Medical Research Council MR/N001796/1Medical Research Council MR/P022642/1Medical Research Council MR/T029188/1Wellcome TrustWellcome Trust WT103767MA
6 · The paper itself

Abstract

The genomes of RNA and small DNA viruses of vertebrates display significant suppression of CpG dinucleotide frequencies. Artificially increasing dinucleotide frequencies results in substantial attenuation of virus replication, suggesting that these compositional changes may facilitate recognition of non-self RNA sequences. Recently, the interferon inducible protein ZAP, was identified as the host factor responsible for sensing CpG in viral RNA, through direct binding and possibly downstream targeting for degradation. Using an arrayed interferon stimulated gene expression library screen, we identified ZAPS, and its associated factor TRIM25, as inhibitors of human cytomegalovirus (HCMV) replication. Exogenous expression of ZAPS and TRIM25 significantly reduced virus replication while knockdown resulted in increased virus replication. HCMV displays a strikingly heterogeneous pattern of CpG representation with specific suppression of CpG motifs within the IE1 major immediate early transcript which is absent in subsequently expressed genes. We demonstrated that suppression of CpG dinucleotides in the IE1 gene allows evasion of inhibitory effects of ZAP. We show that acute virus replication is mutually exclusive with high levels of cellular ZAP, potentially explaining the higher levels of CpG in viral genes expressed subsequent to IE1 due to the loss of pressure from ZAP in infected cells. Finally, we show that TRIM25 regulates alternative splicing between the ZAP short and long isoforms during HCMV infection and interferon induction, with knockdown of TRIM25 resulting in decreased ZAPS and corresponding increased ZAPL expression. These results demonstrate for the first time that ZAP is a potent host restriction factor against large DNA viruses and that HCMV evades ZAP detection through suppression of CpG dinucleotides within the major immediate early 1 transcript. Furthermore, TRIM25 is required for efficient upregulation of the interferon inducible short isoform of ZAP through regulation of alternative splicing.

Indexed as

Alternative SplicingCpG IslandsGene Expression Regulation, ViralVirus ReplicationCell LineCytomegalovirusCytomegalovirus InfectionsHumansImmediate-Early ProteinsRepressor ProteinsRNA-Binding ProteinsTranscription FactorsTripartite Motif ProteinsUbiquitin-Protein LigasesIE1 protein, cytomegalovirusImmediate-Early ProteinsRepressor ProteinsRNA-Binding ProteinsTranscription FactorsTRIM25 protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesYLPM1 protein, human

Identifiers

PMID32886716
PMCPMC7498042
OpenAlexW3083468006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.